{"id":"https://openalex.org/W2195501587","doi":"https://doi.org/10.1080/21548331.2015.1099412","title":"Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study","display_name":"Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study","alternate_titles":[],"publication_year":2015,"publication_date":"2015-11-07","ids":{"openalex":"https://openalex.org/W2195501587","doi":"https://doi.org/10.1080/21548331.2015.1099412","mag":"2195501587","pmid":"https://pubmed.ncbi.nlm.nih.gov/26549305"},"language":"en","primary_location":{"id":"doi:10.1080/21548331.2015.1099412","doi":"https://doi.org/10.1080/21548331.2015.1099412","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21548331.2015.1099412","pdf_url":"https://escholarship.org/content/qt7mc7g4jb/qt7mc7g4jb.pdf?t=o17c3z","source":{"id":"https://openalex.org/S4210173941","display_name":"Hospital Practice","issn_l":"0018-5809","issn":["0018-5809","2154-8331","2377-1003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hospital Practice","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2195501587"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://escholarship.org/content/qt7mc7g4jb/qt7mc7g4jb.pdf?t=o17c3z","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109652161","display_name":"Ronald Preblick","orcid":"https://orcid.org/0000-0002-7923-041X","observed_orcids":["https://orcid.org/0000-0002-7923-041X"]},"institutions":[{"id":"https://openalex.org/I4210162815","display_name":"Daiichi Sankyo (United States)","ror":"https://ror.org/055werx92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104626","https://openalex.org/I4210162815"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald Preblick","raw_affiliation_strings":["a Health Economics and Outcomes Research, Daiichi Sankyo, Inc ., Parsippany , NJ , USA","Health Economics and Outcomes Research, Daiichi Sankyo, Inc., Parsippany, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Health Economics and Outcomes Research, Daiichi Sankyo, Inc ., Parsippany , NJ , USA","institution_ids":["https://openalex.org/I4210162815"]},{"raw_affiliation_string":"Health Economics and Outcomes Research, Daiichi Sankyo, Inc., Parsippany, NJ, USA","institution_ids":["https://openalex.org/I4210162815"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113504119","display_name":"Winghan Jacqueline Kwong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162815","display_name":"Daiichi Sankyo (United States)","ror":"https://ror.org/055werx92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104626","https://openalex.org/I4210162815"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"W. Jacqueline Kwong","raw_affiliation_strings":["a Health Economics and Outcomes Research, Daiichi Sankyo, Inc ., Parsippany , NJ , USA","Health Economics and Outcomes Research, Daiichi Sankyo, Inc., Parsippany, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Health Economics and Outcomes Research, Daiichi Sankyo, Inc ., Parsippany , NJ , USA","institution_ids":["https://openalex.org/I4210162815"]},{"raw_affiliation_string":"Health Economics and Outcomes Research, Daiichi Sankyo, Inc., Parsippany, NJ, USA","institution_ids":["https://openalex.org/I4210162815"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107094717","display_name":"Richard H. R. White","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I4210160856","display_name":"UC Davis Health","ror":"https://ror.org/05q8kyc69","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard H. White","raw_affiliation_strings":["b Division of General Medicine, Anticoagulation Service , University of California Davis Health System , Sacramento , CA , USA","Division of General Medicine, Anticoagulation Service, University of California Davis Health System, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b Division of General Medicine, Anticoagulation Service , University of California Davis Health System , Sacramento , CA , USA","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I4210160856","https://openalex.org/I84218800"]},{"raw_affiliation_string":"Division of General Medicine, Anticoagulation Service, University of California Davis Health System, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I4210160856","https://openalex.org/I84218800"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021368492","display_name":"Samuel Zachary Goldhaber","orcid":"https://orcid.org/0000-0002-6450-0448","observed_orcids":["https://orcid.org/0000-0002-6450-0448"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel Z. Goldhaber","raw_affiliation_strings":["c Cardiovascular Division , Brigham and Women's Hospital , Boston , MA , USA","Cardiovascular Division, Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"c Cardiovascular Division , Brigham and Women's Hospital , Boston , MA , USA","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Cardiovascular Division, Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5113504119"],"corresponding_institution_ids":["https://openalex.org/I4210162815"],"apc_list":null,"apc_paid":null,"fwci":4.0159,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.93099207,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"43","issue":"5","first_page":"249","last_page":"257"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/edoxaban","display_name":"edoxaban","score":1.0},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9340000152587891},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9229999780654907},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9919999837875366},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.5550000071525574},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8429999947547913}],"concepts":[{"id":"https://openalex.org/C2780290652","wikidata":"https://www.wikidata.org/wiki/Q21011234","display_name":"Edoxaban","level":5,"score":0.981844425201416},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9750609397888184},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8627306222915649},{"id":"https://openalex.org/C2991741193","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thromboembolism","level":3,"score":0.5772175192832947},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5133206248283386},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.43114209175109863},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42659568786621094},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2880585491657257},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2290005087852478},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.07049775123596191},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.05973392724990845}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054556","descriptor_name":"Venous Thromboembolism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054556","descriptor_name":"Venous Thromboembolism","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1080/21548331.2015.1099412","doi":"https://doi.org/10.1080/21548331.2015.1099412","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21548331.2015.1099412","pdf_url":"https://escholarship.org/content/qt7mc7g4jb/qt7mc7g4jb.pdf?t=o17c3z","source":{"id":"https://openalex.org/S4210173941","display_name":"Hospital Practice","issn_l":"0018-5809","issn":["0018-5809","2154-8331","2377-1003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hospital Practice","raw_type":"journal-article"},{"id":"pmid:26549305","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26549305","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hospital practice (1995)","raw_type":"Journal Article"},{"id":"pmh:oai:escholarship.org/ark:/13030/qt7mc7g4jb","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/7mc7g4jb","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hospital practice (1995), vol 43, iss 5","raw_type":"article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt7mc7g4jb","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/7mc7g4jb","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hospital Practice, vol 43, iss 5","raw_type":"article"},{"id":"pmh:qt7mc7g4jb","doi":null,"is_oa":false,"landing_page_url":"http://www.escholarship.org/uc/item/7mc7g4jb","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Preblick, R; Kwong, WJ; White, RH; &amp; Goldhaber, SZ. (2015). Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study. Hospital practice (1995), 43(5), 249 - 257. doi: 10.1080/21548331.2015.1099412. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/7mc7g4jb","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/21548331.2015.1099412","doi":"https://doi.org/10.1080/21548331.2015.1099412","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21548331.2015.1099412","pdf_url":"https://escholarship.org/content/qt7mc7g4jb/qt7mc7g4jb.pdf?t=o17c3z","source":{"id":"https://openalex.org/S4210173941","display_name":"Hospital Practice","issn_l":"0018-5809","issn":["0018-5809","2154-8331","2377-1003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hospital Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2195501587.pdf","grobid_xml":"https://content.openalex.org/works/W2195501587.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W59725187","https://openalex.org/W106352447","https://openalex.org/W1184073023","https://openalex.org/W1512398135","https://openalex.org/W1970405391","https://openalex.org/W1983727955","https://openalex.org/W1987938439","https://openalex.org/W2008955498","https://openalex.org/W2011000634","https://openalex.org/W2011127570","https://openalex.org/W2029294627","https://openalex.org/W2044689068","https://openalex.org/W2045201722","https://openalex.org/W2053483663","https://openalex.org/W2055974666","https://openalex.org/W2067254496","https://openalex.org/W2072727975","https://openalex.org/W2074708727","https://openalex.org/W2076480499","https://openalex.org/W2081001722","https://openalex.org/W2081139146","https://openalex.org/W2088673482","https://openalex.org/W2094559045","https://openalex.org/W2099397006","https://openalex.org/W2102778065","https://openalex.org/W2110145942","https://openalex.org/W2115787552","https://openalex.org/W2117966469","https://openalex.org/W2118092611","https://openalex.org/W2130199362","https://openalex.org/W2131099415","https://openalex.org/W2134047636","https://openalex.org/W2134430286","https://openalex.org/W2144714162","https://openalex.org/W2160625453","https://openalex.org/W2166402206","https://openalex.org/W2323297041","https://openalex.org/W2345055725","https://openalex.org/W2551320863","https://openalex.org/W2554350949","https://openalex.org/W2984280663"],"related_works":["https://openalex.org/W4233346127","https://openalex.org/W2811247937","https://openalex.org/W2054234916","https://openalex.org/W3048792874","https://openalex.org/W2905785628","https://openalex.org/W2052412669","https://openalex.org/W2164058372","https://openalex.org/W2766528426","https://openalex.org/W2810237727","https://openalex.org/W2802590050"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Venous":[1],"thromboembolism":[2],"(VTE)":[3],"is":[4,41,218],"associated":[5],"with":[6,30,70,114],"almost":[7],"300,000":[8],"deaths":[9],"per":[10,147,164,181],"year":[11,168],"in":[12,74,187,198],"the":[13,44,54,76,103,110,126,157,203,225],"United":[14],"States.":[15],"Novel":[16],"oral":[17],"anticoagulants":[18],"(NOACs)":[19],"offer":[20],"an":[21,178],"alternative":[22,221],"to":[23,93,101,185,196,222],"warfarin-based":[24],"therapy":[25],"without":[26],"monitoring":[27],"requirements":[28],"and":[29,33,46,81,86,135,143,205],"fewer":[31],"drug":[32,136,214],"food":[34],"interactions.":[35],"Edoxaban,":[36],"a":[37,151,219],"direct":[38],"Xa":[39],"inhibitor,":[40],"approved":[42],"by":[43],"Food":[45],"Drug":[47],"Administration":[48],"(FDA),":[49],"based":[50],"upon":[51],"results":[52],"of":[53,78,97,105,112,141,145,189,207,227],"Hokusai-VTE":[55,127],"Phase":[56],"3":[57],"trial.":[58],"The":[59,95,192],"trial":[60],"demonstrated":[61],"that":[62,175],"edoxaban":[63,106,144,176,217],"administered":[64],"once":[65],"daily":[66],"after":[67],"initial":[68],"treatment":[69,111,226],"heparin":[71],"was":[72,100,120,162,194],"non-inferior":[73],"reducing":[75],"risk":[77],"VTE":[79],"recurrence":[80],"caused":[82],"significantly":[83],"less":[84],"major":[85],"clinically":[87],"relevant":[88],"non-major":[89],"(CRNM)":[90],"bleeding":[91],"compared":[92],"warfarin.":[94],"objective":[96],"this":[98],"study":[99],"evaluate":[102],"cost-effectiveness":[104,118,159],"versus":[107],"warfarin":[108,140,186,208,223],"for":[109,139,224],"adults":[113],"VTE.":[115,228],"METHODS:":[116],"A":[117],"model":[119,190,200],"developed":[121],"using":[122],"patient-level":[123],"data":[124],"from":[125,132],"trial,":[128],"clinical":[129],"event":[130],"costs":[131,138],"real-world":[133],"databases,":[134],"acquisition":[137,215],"$0.36":[142],"$9.24":[146],"tablet.":[148],"RESULTS:":[149],"From":[150],"U.S.":[152],"health-care":[153],"delivery":[154],"system":[155],"perspective,":[156],"incremental":[158],"ratio":[160],"(ICER)":[161],"$22,057":[163],"quality":[165],"adjusted":[166],"life":[167],"(QALY)":[169],"gained.":[170],"Probabilistic":[171],"sensitivity":[172],"analysis":[173],"showed":[174],"had":[177],"ICER":[179],"<$50,000":[180],"QALY":[182],"gained":[183],"relative":[184],"67%":[188],"simulations.":[191],"result":[193],"robust":[195],"variation":[197],"key":[199],"parameters":[201],"including":[202],"cost":[204],"disutility":[206],"monitoring.":[209],"CONCLUSION:":[210],"Despite":[211],"its":[212],"higher":[213],"cost,":[216],"cost-effective":[220]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2195501587","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
